Burning Rock Biotech Limited (BNR)

Burning Rock Biotech Revenue

Burning Rock Biotech had revenue of 148.55M CNY in the quarter ending June 30, 2025, with 9.61% growth. This brings the company's revenue in the last twelve months to 536.30M, up 5.20% year-over-year. In the year 2024, Burning Rock Biotech had annual revenue of 515.82M, down -4.02%.

• Revenue (ttm): 536.30M CNY
• Revenue Growth: +5.20%
• P/S Ratio: 1.20
• Revenue / Employee: 795,700 CNY
• Employees: 674
• Market Cap: 89.04M USD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	515.82M	-21.61M	-4.02%
Dec 31, 2023	537.44M	-25.80M	-4.58%
Dec 31, 2022	563.24M	55.38M	10.90%
Dec 31, 2021	507.86M	77.96M	18.13%
Dec 31, 2020	429.90M	48.23M	12.64%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.